Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 359.8 | 349.0 | 330.4 | 295.6 | 267.5 | 310.7 | 327.1 | 410.2 |
| Revenue growth | 3.1% | 5.6% | 11.8% | 10.5% | -13.9% | -5.0% | -20.3% | 10.5% |
| Cost of goods sold | 130.5 | 143.2 | 149.4 | 141.6 | 111.0 | 133.2 | 150.3 | 126.9 |
| Gross profit | 229.2 | 205.9 | 181.0 | 154.0 | 156.5 | 177.5 | 176.8 | 283.3 |
| Gross margin | 63.7% | 59.0% | 54.8% | 52.1% | 58.5% | 57.1% | 54.0% | 69.1% |
| Selling, general and administrative | 149.6 | 148.4 | 141.4 | 142.9 | 109.6 | 114.8 | 130.8 | 127.2 |
| Research and development | 52.9 | 50.2 | 47.7 | 57.9 | 63.6 | 67.9 | 77.4 | |
| EBITA | 40.1 | 7.2 | -17.4 | -37.2 | -16.6 | -5.2 | -33.6 | -179.2 |
| EBITA margin | 11.1% | 2.1% | -5.3% | -12.6% | -6.2% | -1.7% | -10.3% | -43.7% |
| Amortization of intangibles | 13.4 | | | | | | | 13.5 |
| EBIT | 26.7 | 7.2 | -17.4 | -37.2 | -16.6 | -5.2 | -33.6 | -192.6 |
| EBIT margin | 7.4% | 2.1% | -5.3% | -12.6% | -6.2% | -1.7% | -10.3% | -47.0% |
| Pre-tax income | 10.8 | -3.6 | -15.2 | -46.5 | -26.8 | -8.1 | -24.1 | -242.0 |
| Income taxes | 0.7 | 0.2 | 1.2 | -35.9 | 1.4 | 2.2 | -0.2 | 65.9 |
| Tax rate | 6.8% | | | 77.0% | | | 0.7% | |
| Net income | 10.1 | -3.8 | -16.3 | -10.7 | -28.2 | -10.2 | -23.9 | -307.9 |
| Net margin | 2.8% | -1.1% | -4.9% | -3.6% | -10.5% | -3.3% | -7.3% | -75.1% |
| |
| Diluted EPS | $0.13 | ($0.05) | ($0.23) | ($0.15) | ($0.40) | ($0.15) | ($0.35) | ($4.49) |
| Shares outstanding (diluted) | 80.7 | 73.2 | 71.4 | 70.3 | 70.9 | 68.9 | 68.7 | 68.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|